Clay Siegall is currently the chief executive officer of Seattle Genetics, a biotechnology company that has transformed the lives of many people who have cancer. The scientist is also the president and chairman of the board of directors in the biotechnology company. Siegall founded the company in 1998, and since then, he has worked tirelessly to lead the organization to great advancements in cancer therapies and cancer research.
Siegall acquired his Ph.D. from the prestigious George Washington University. After completing his studies, Clay ventured into the genetic industry. He started his career by working as a senior research investigator at an institution known as Bristol-Myers Squibb Pharmaceutical Research Institute. He worked in the organization for some time before being promoted to the position of Principal Scientist. Siegall also worked at the National Cancer Institute before launching Seattle Genetics.
Apart from being a respected leader in the cancer industry, Dr. Siegall has shown excellent abilities in leadership. As the chief executive officer and chairman of Seattle Genetics, Clay Siegall recently led a campaign to raise more than one billion dollars in private and public funding. The money raised during the campaign will enable the company to advance in cancer treatments using the latest technology.
Clay has received several awards due to his significant contributions in the medical and scientific industry. Some of these include the University of Maryland Alumnus of the Year for Computer, Math and Natural Sciences. The scientist was also recognized as the Pacific Northwest Ernst &Young Entrepreneur of the Year in 2012.
Siegall is not showing any signs of slowing down. The successful scientist is one of the leaders in the competitive industry thanks to his achievements. At the moment, Clay has written more than seventy scientific articles. Through these articles, Siegall shares his in-depth knowledge of the medical and scientific industries around the globe. Clay holds fifteen patents, and reports say that he is working hard to reach new heights in cancer research. Siegall holds several prominent positions on various boards. His contributions to respected scientific journals have made him one of the most influential professionals in the industry.